Does Medicare Cover
Testosterone Therapy?

If you're on Medicare and experiencing symptoms of low testosterone — fatigue, brain fog, low libido, muscle loss, mood changes — you're not alone. Low testosterone affects roughly 40% of men over 65, yet many Medicare beneficiaries assume their coverage doesn't include testosterone therapy. The reality is more nuanced: Medicare does cover FDA-approved testosterone medications through Part D, but there are specific diagnostic requirements, formulary considerations, and plan variations that determine exactly what you'll pay.

At Revive Low T Clinic, we treat men across the age spectrum — from their 30s through their 70s and beyond. Many of our patients over 65 are on Medicare, and we have extensive experience navigating Medicare's coverage rules for testosterone therapy. This guide covers everything a Medicare beneficiary needs to know about TRT coverage in 2026.

Understanding Medicare's Structure for TRT

Medicare isn't a single plan — it's a system of interconnected parts, and TRT touches several of them. Here's how each part relates to testosterone therapy:

Medicare Part A (Hospital Insurance)

Part A covers inpatient hospital stays, skilled nursing, and hospice. It's not directly relevant to routine TRT, but it's worth noting that if you were hospitalized and needed testosterone administered during your stay, Part A would cover it as part of your inpatient care.

Medicare Part B (Medical Insurance)

Part B covers outpatient medical services, including doctor visits and diagnostic lab work. For TRT patients, Part B is relevant because it covers the blood tests needed to diagnose and monitor low testosterone. Diagnostic hormone panels — total testosterone, free testosterone, LH, FSH, CBC, CMP, and related tests — are covered under Part B when ordered by a physician with a valid medical indication.

Important note: Part B covers lab work at 100% with no coinsurance when performed at a Medicare-participating lab. Quest Diagnostics and LabCorp, which are the most common national lab networks, both participate in Medicare. At Revive, your lab work is included in your first visit and ongoing plan, so your Part B benefit may provide additional reimbursement depending on how your plan handles out-of-network lab services.

Medicare Part D (Prescription Drug Coverage)

Part D is where testosterone medication coverage lives. Part D is a separate prescription drug plan that you can add to Original Medicare (Parts A + B) or get bundled with a Medicare Advantage plan (Part C). Most Part D formularies include generic testosterone cypionate as a covered medication.

The specifics of your Part D coverage — copay amounts, formulary tier, prior authorization requirements, and preferred pharmacies — depend on which Part D plan you've selected. There are dozens of Part D plans available in Washington state, each with slightly different formulary designs. However, the general pattern is consistent: generic injectable testosterone is covered at a reasonable copay on the vast majority of Part D plans.

Medicare Advantage (Part C)

Medicare Advantage plans (offered by private insurers like UnitedHealthcare, Humana, Aetna, Kaiser, and Regence) bundle Parts A, B, and usually D into a single plan. If you have a Medicare Advantage plan, your testosterone coverage is determined by that plan's specific formulary. Most Medicare Advantage plans in Washington include generic testosterone on their drug formulary, but copays and prior authorization requirements vary by plan.

Diagnostic Requirements for Medicare TRT Coverage

Medicare has specific diagnostic criteria that must be met before testosterone therapy will be covered. These requirements are stricter than what most commercial insurance plans require:

Two Morning Blood Draws

Medicare requires documentation of low testosterone on two separate morning blood draws (typically before 10 AM). Testosterone levels naturally fluctuate throughout the day, with the highest levels occurring in the early morning. By requiring two separate low readings, Medicare ensures that a single aberrant result doesn't lead to unnecessary treatment.

At Revive, we build this into our diagnostic process. Your first visit includes a morning blood draw with a comprehensive panel. If your total testosterone comes back below the clinical threshold (generally below 300 ng/dL), we schedule a second confirmatory draw, typically 2–4 weeks later. Both results are documented in your medical record and included with any prior authorization submissions.

Clinical Diagnosis of Hypogonadism

Medicare requires a formal diagnosis of hypogonadism — not just low lab values. This means your physician must document clinical signs and symptoms of testosterone deficiency (fatigue, decreased libido, erectile dysfunction, loss of muscle mass, depressed mood, etc.) in addition to the lab confirmation. A physician can't simply write a prescription based on numbers alone — there must be a clinical correlation.

This is one area where Revive's in-person model provides a real advantage over telehealth. Our physicians perform a thorough physical exam and detailed symptom assessment that creates a robust clinical record. This documentation is exactly what Medicare needs to see when approving testosterone coverage.

Ruling Out Other Causes

Medicare expects your physician to rule out other potential causes of low testosterone before initiating therapy. This includes checking for thyroid disorders, pituitary tumors (via prolactin levels), chronic illness, medication effects, and obstructive sleep apnea. Our 51-analyte lab panel covers all of these — thyroid function, prolactin, metabolic markers, and more — so alternative diagnoses are either identified or ruled out during the initial evaluation.

Part D Formulary Tiers and Testosterone Copays

Medicare Part D plans use a tiered formulary system. While the exact tiers and copays vary by plan, here's the general structure and where testosterone medications typically fall:

• Tier 1 — Preferred Generic: $1–10 copay. Some Part D plans place generic testosterone cypionate here. This is the best-case scenario for Medicare patients.
• Tier 2 — Generic: $10–25 copay. Most Part D plans place generic injectable testosterone at this tier. Still very affordable.
• Tier 3 — Preferred Brand: $30–60 copay or 25% coinsurance. Brand testosterone products (AndroGel, Testim) may fall here if covered at all.
• Tier 4 — Non-Preferred Drug: $60–100+ copay or 25–50% coinsurance. Some brand topical testosterone formulations may land here.
• Tier 5 — Specialty: Typically 25–33% coinsurance. Not usually applicable to testosterone, but some specialty formulations could be classified here.

The practical takeaway: most Medicare patients pay between $5 and $25 per month for generic injectable testosterone cypionate through their Part D plan. We always prescribe the form most likely to be covered at the lowest copay — which is almost always generic injectable testosterone cypionate.

Medicare Advantage Plans and TRT

Medicare Advantage plans are offered by private insurers and combine your medical and prescription drug coverage into one plan. In Washington state, popular Medicare Advantage carriers include UnitedHealthcare (AARP), Humana, Aetna, Kaiser Permanente, Regence, and Premera.

Each Medicare Advantage plan has its own formulary, prior authorization rules, and pharmacy network. Some key differences between Advantage plans and Original Medicare + Part D for TRT patients:

• Network restrictions: Some Advantage plans (especially HMOs) may require you to see in-network providers. Revive is not typically in-network for Medicare Advantage plans, but your prescription can still be filled at any in-network pharmacy using your plan's drug benefit.
• Prior authorization: Advantage plans may have different PA requirements than Original Medicare. Some require PA for all testosterone prescriptions; others only for brand-name formulations.
• Copay structure: Advantage plans set their own copay amounts, which may differ from standalone Part D plans. However, generic testosterone copays are generally competitive across most Advantage plans.
• Kaiser Advantage: If you have Kaiser Medicare Advantage, see our Kaiser TRT coverage guide for specific details, as Kaiser's closed pharmacy system adds additional considerations.

Medicare Supplement (Medigap) Plans

Medigap plans supplement Original Medicare by covering some or all of the out-of-pocket costs that Parts A and B don't cover — deductibles, coinsurance, and copays for medical services. However, Medigap plans do NOT include prescription drug coverage. If you have Original Medicare + Medigap, you need a separate Part D plan for testosterone medication coverage.

The advantage of Original Medicare + Medigap + Part D for TRT patients is flexibility: you can see any provider who accepts Medicare (no network restrictions), fill prescriptions at any pharmacy in your Part D network, and your Medigap plan helps cover the coinsurance for lab work and diagnostic services.

The Part D Coverage Gap ("Donut Hole")

One concern Medicare patients sometimes have is the Part D coverage gap — informally known as the "donut hole." This is the period between when your initial coverage limit is reached and when catastrophic coverage begins. During the coverage gap, you're responsible for a larger share of your drug costs.

For TRT patients, the good news is that generic testosterone cypionate is inexpensive enough that it has minimal impact on your coverage gap calculations. At $30–60 per fill (before insurance), your testosterone prescription is unlikely to push you into the coverage gap on its own. And even within the gap, generic drug discounts mean you'll pay no more than 25% of the cost — which for generic testosterone amounts to roughly $8–15 per fill.

Under the Inflation Reduction Act provisions that took effect in 2025, Medicare Part D out-of-pocket costs are now capped at $2,000 per year — providing additional protection for patients who take multiple medications.

What Medicare Patients Pay at Revive

Here's a transparent breakdown of what Medicare patients typically pay for TRT care at Revive:

That's $480–720 per year for comprehensive, physician-supervised TRT with in-person exams, comprehensive lab work, and medication covered by your Part D plan. Compare that to telehealth TRT companies charging $1,800–3,000/year for the same medication without insurance coverage, minimal lab work, and no physical exam.

TRT Safety Monitoring for Medicare Patients

Men over 65 may have additional health considerations that make comprehensive monitoring especially important on TRT. At Revive, our protocol for older patients includes careful attention to:

• Hematocrit and hemoglobin: TRT can increase red blood cell production. We monitor this closely and adjust dosing if levels get too high.
• PSA (Prostate-Specific Antigen): While TRT does not cause prostate cancer, monitoring PSA is standard practice for men over 50 on testosterone therapy.
• Cardiovascular markers: Lipid panel, blood pressure, and inflammatory markers are included in our monitoring protocol. The TRAVERSE trial (published 2023) demonstrated that TRT does not increase cardiovascular risk in men with hypogonadism — but diligent monitoring remains best practice.
• Estradiol: Estrogen management becomes more important with age as aromatase activity increases. We monitor and manage estradiol levels to prevent side effects.
• Bone density considerations: Testosterone plays a role in bone mineral density, and TRT can help prevent osteoporosis in hypogonadal men — a significant benefit for Medicare-age patients.

The TRAVERSE Trial: What Medicare Patients Should Know

The TRAVERSE trial, published in the New England Journal of Medicine in 2023, was the largest randomized controlled trial ever conducted on TRT cardiovascular safety. It enrolled over 5,200 men aged 45–80 with hypogonadism and either pre-existing cardiovascular disease or high cardiovascular risk. The trial's primary finding: testosterone therapy did not increase the rate of major adverse cardiovascular events compared to placebo.

This is particularly relevant for Medicare patients, who are more likely to have cardiovascular risk factors. The TRAVERSE trial provides reassuring evidence that properly monitored TRT is cardiovascularly safe in older men — the exact population that Medicare serves. This trial data has influenced Medicare's coverage policies positively, and we reference it in our clinical documentation when appropriate.

Common Medicare TRT Questions

Is there an age limit for TRT on Medicare?

No. Medicare does not impose an age limit on testosterone therapy. Coverage is based on medical necessity — a confirmed diagnosis of hypogonadism with documented symptoms — not age. We treat men in their 70s and beyond who benefit significantly from properly managed TRT.

Will Medicare cover testosterone gel instead of injections?

Most Part D plans cover generic testosterone gel, though copays are typically higher than for injectable testosterone. Brand-name gels like AndroGel may require prior authorization and carry Tier 3 or Tier 4 copays. If you prefer a topical formulation, we'll work with your Part D plan to find the most cost-effective option.

Can I use my Medicare HSA for Revive membership?

If you have a Medicare Savings Account (MSA) plan — a type of Medicare Advantage with a health savings account — you may be able to use those funds for qualified medical expenses, including clinic membership fees. Traditional Medicare does not include an HSA, but if you contributed to an HSA before enrolling in Medicare, you can use those existing funds for medical expenses including TRT-related costs.

What if my Part D plan doesn't cover testosterone?

This is rare for generic injectable testosterone, but if it occurs, you have options: request a formulary exception from your Part D plan (we handle the paperwork), switch to a Part D plan that includes testosterone during the next Annual Enrollment Period (October 15 – December 7), or pay cash at a local pharmacy using a discount program like GoodRx. Even at cash price, generic testosterone cypionate typically costs $30–60 per fill — still far less than telehealth pricing.

Does Medicare cover the Revive first visit?

Revive's clinic membership is a direct-pay service and is not billed through Medicare. Your first visit ($99) and ongoing membership ($35–269/month) are paid directly to Revive. However, these costs may be tax-deductible as medical expenses if your total medical costs exceed 7.5% of your adjusted gross income — a threshold that many Medicare beneficiaries meet. Consult your tax advisor for specific guidance.

Getting Started as a Medicare Patient

If you're on Medicare and ready to address low testosterone, here's the path forward at Revive:

• Step 1: Book your first visit ($99) — physician consultation + 51-analyte lab panel, including the initial morning testosterone draw.
• Step 2: If initial results indicate low T, we schedule a second confirmatory morning draw (required by Medicare for coverage).
• Step 3: With both lab results confirmed, your physician prescribes testosterone to the pharmacy of your choice. We verify your Part D formulary and optimize the prescription for lowest copay.
• Step 4: Pick up your medication using your Part D benefit — typical copay: $5–25/month.

Bring your Medicare card and Part D plan information to your first appointment. We'll verify your exact coverage and ensure everything is set up correctly from the start. For full details on how we work with all insurance carriers, visit our insurance coverage page.